Serena G. Liao
Alexion Pharmaceuticals (United States)(US)AstraZeneca (United States)(US)
Publications by Year
Research Areas
Epigenetics and DNA Methylation, Cancer-related gene regulation, Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Estrogen and related hormone effects
Most-Cited Works
- → An R package suite for microarray meta-analysis in quality control, differentially expressed gene analysis and pathway enrichment detection(2012)208 cited
- → Missing value imputation in high-dimensional phenomic data: imputable or not, and how?(2014)152 cited
- → The molecular landscape of premenopausal breast cancer(2015)98 cited
- → Phase Ib Study of the Anti-TIM-3 Antibody MBG453 in Combination with Decitabine in Patients with High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)(2019)85 cited
- → Paclitaxel With Inhibitor of Apoptosis Antagonist, LCL161, for Localized Triple-Negative Breast Cancer, Prospectively Stratified by Gene Signature in a Biomarker-Driven Neoadjuvant Trial(2018)73 cited
- → Efficacy and Safety of Sabatolimab (MBG453) in Combination with Hypomethylating Agents (HMAs) in Patients with Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (HR-MDS): Updated Results from a Phase 1b Study(2020)69 cited
- → Whole-Genome Methylation Sequencing Reveals Distinct Impact of Differential Methylations on Gene Transcription in Prostate Cancer(2013)54 cited
- → Phase Ib/II study of lacnotuzumab (MCS110) combined with spartalizumab (PDR001) in patients (pts) with advanced tumors.(2018)43 cited
- → Bias correction for selecting the minimal-error classifier from many machine learning models(2014)26 cited
- → Targeted DNA Methylation Screen in the Mouse Mammary Genome Reveals a Parity-Induced Hypermethylation of Igf1r That Persists Long after Parturition(2015)19 cited